Advanced Search

Technical Analysis for IGMS - IGM Biosciences, Inc.

Grade Last Price % Change Price Change
grade A 60.01 4.00% 2.31
IGMS closed up 4.0 percent on Friday, April 3, 2020, on 34 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.
0 Watchers
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A Up Up
Historical IGMS trend table...
Date Alert Name Type % Chg
Multiple of Ten Bullish Other 0.00%
Wide Bands Range Expansion 0.00%
Overbought Stochastic Strength 0.00%
Wide Bands Range Expansion 4.00%
Overbought Stochastic Strength 4.00%
20 DMA Support Bullish 17.41%
50 DMA Support Bullish 17.41%
Multiple of Ten Bullish Other 17.41%
Wide Bands Range Expansion 17.41%
Overbought Stochastic Strength 17.41%
Older EOD signals for IGMS ...
View Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
IGMS Chart by TradingView
Basic chart:

Profile

Headquartered in Mountain View, California, IGM Biosciences is a biotechnology company focused on creating and developing engineered IgM antibodies for the treatment of cancer patients. Since 2010, IGM Biosciences has worked to overcome the manufacturing and protein engineering hurdles that have limited the therapeutic use of IgM antibodies. Through its efforts, IGM Biosciences has created a proprietary IgM technology platform for the development of IgM antibodies for those clinical indications where their inherent properties may provide advantages as compared to IgG antibodies.
Biotechnology Cancer Manufacturing Medical Specialties Immunology Treatment Of Cancer Antibodies Glycoproteins Biochemistry Protein Engineering

Is IGMS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Apr 3 IGM Biosciences to Participate in Canaccord Genuity Horizons in Oncology Virtual Event
Mar 27 IGM Biosciences, Inc. (IGMS) CEO Fred Schwarzer on Q4 2019 Results - Earnings Call Transcript
Mar 26 IGM Biosciences EPS misses by $0.06
Mar 26 IGM Biosciences Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
Mar 26 IGM Biosciences Inc to Host Earnings Call
Mar 22 The Week Ahead In Biotech: Bristol-Myers, Rockwell Medical Await FDA Decisions, COVID-19 Updates In Focus
Mar 19 IGM Biosciences to Announce Fourth Quarter and Year-end 2019 Financial Results and Host Conference Call and Webcast on March 26, 2020
Mar 13 Key events next week - healthcare
Mar 7 Stocks To Watch: Fading The Fear
Mar 6 101 Biggest Movers From Yesterday
See more IGMS news...

Indicators

Indicator Value
52 Week High 74.13
52 Week Low 16.1
Average Volume 130,149
200-Day Moving Average 0.00
50-Day Moving Average 47.32
20-Day Moving Average 46.80
10-Day Moving Average 51.57
Average True Range 8.25
ADX 17.72
+DI 26.34
-DI 20.06
Chandelier Exit (Long, 3 ATRs ) 47.99
Chandelier Exit (Short, 3 ATRs ) 52.31
Upper Bollinger Band 62.66
Lower Bollinger Band 30.93
Percent B (%b) 0.92
BandWidth 67.81
MACD Line 2.18
MACD Signal Line 0.66
MACD Histogram 1.5115
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 71.83
Resistance 3 (R3) 70.81 65.84 69.86
Resistance 2 (R2) 65.84 62.83 66.36 69.20
Resistance 1 (R1) 62.93 60.97 64.39 63.95 68.55
Pivot Point 57.96 57.96 58.69 58.48 57.96
Support 1 (S1) 55.05 54.95 56.51 56.07 51.47
Support 2 (S2) 50.08 53.09 50.60 50.82
Support 3 (S3) 47.17 50.08 50.16
Support 4 (S4) 48.19